Side Effects of orphenadrine: A Synthesis of Findings from 30 Studies
- Home
- Side Effects of orphenadrine
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Side Effects of orphenadrine: A Synthesis of Findings from 30 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Main Research Findings
Orphenadrine is an anticholinergic drug often used to treat neurological conditions like Parkinson's disease and antipsychotic-induced dyskinesia. 28 points out a lack of thorough pharmacokinetic data for orphenadrine, particularly in elderly patients, which might hinder its safe and effective use. The study suggests that orphenadrine is absorbed quickly after oral administration, distributes widely in the body, and is extensively metabolized. 14 raises concerns about long-term anticholinergic use, indicating that it might contribute to tardive dyskinesia caused by antipsychotics. suggests potential benefits of orphenadrine in treating muscle cramps experienced by patients with cirrhosis, while 20 further supports this with pilot study results demonstrating orphenadrine's effectiveness for muscle cramps in this patient group. 23 emphasizes the seriousness of orphenadrine intoxication, warning that it can lead to severe adverse effects with life-threatening consequences. 16 identifies a potential mechanism for cardiac complications, showing that orphenadrine inhibits HERG channels, potentially leading to QT prolongation and torsades de pointes tachycardia.
Reasons for Side Effects
Orphenadrine's anticholinergic properties are the root cause of its diverse side effects. 28 highlights the concern that insufficient pharmacokinetic information about orphenadrine might impede its safe and effective use in the elderly. 14 suggests a possible link between long-term use of anticholinergics and tardive dyskinesia induced by antipsychotics. 16 reveals that orphenadrine can inhibit HERG channels, potentially contributing to QT prolongation and torsades de pointes tachycardia. Orphenadrine's central nervous system activity also contributes to side effects like drowsiness and decreased consciousness. 23 stresses the severe consequences of orphenadrine poisoning, which can be life-threatening.
Common Side Effects
Dry Mouth
Orphenadrine's effect on salivary secretion, reducing its production, can lead to dry mouth. reports dry mouth as a potential side effect of orphenadrine.
Constipation
Orphenadrine's ability to slow down intestinal movement can result in constipation. lists constipation as a possible side effect associated with orphenadrine.
Blurred Vision
Orphenadrine can cause blurred vision due to its effect of constricting the pupils of the eyes. 19 reports blurred vision as a side effect of orphenadrine.
Dizziness
Orphenadrine's action on the central nervous system can lead to dizziness. 19 reports dizziness as a possible side effect of orphenadrine.
Drowsiness
Orphenadrine's impact on the central nervous system can result in drowsiness and other side effects. 27 mentions sedation as a potential side effect associated with antispastic drugs, including orphenadrine. 17 presents research findings showing a pain-relieving effect from combining orphenadrine with diclofenac.
Decreased Level of Consciousness
Orphenadrine's effects on the central nervous system can lead to a decreased level of consciousness and other side effects. 1 reports decreased consciousness as a side effect of prochlorperazine (a drug used as an antipsychotic similar to orphenadrine).
QT Prolongation
Orphenadrine can cause QT prolongation by inhibiting HERG channels. 16 discovers that orphenadrine can inhibit HERG channels, potentially leading to QT prolongation and torsades de pointes tachycardia.
Torsades de Pointes Tachycardia
Orphenadrine can cause QT prolongation and torsades de pointes tachycardia by inhibiting HERG channels. 16 discovers that orphenadrine can inhibit HERG channels, potentially leading to QT prolongation and torsades de pointes tachycardia.
Toxicity
Orphenadrine can lead to toxicity. 23 emphasizes the potential severity of orphenadrine poisoning, which can have life-threatening consequences.
Measures to Counteract Side Effects
Measures for Dry Mouth
Managing dry mouth can involve drinking plenty of fluids. Chewing xylitol-containing gum or tablets can also be helpful.
Measures for Constipation
Constipation can be addressed by increasing dietary fiber intake and engaging in regular exercise. Laxatives may be used if necessary.
Measures for Blurred Vision
Addressing blurred vision might involve reducing or discontinuing orphenadrine dosage. Wearing glasses or contact lenses can also be beneficial.
Measures for Dizziness
Managing dizziness can involve reducing or discontinuing orphenadrine dosage. Getting up slowly to avoid falls is essential.
Measures for Drowsiness
Managing drowsiness might involve reducing or discontinuing orphenadrine dosage. It's crucial to avoid driving or operating machinery.
Measures for Decreased Level of Consciousness
Decreased level of consciousness is a serious side effect and requires immediate medical attention.
Measures for QT Prolongation
QT prolongation can increase the risk of arrhythmias and should be reported to a doctor immediately.
Measures for Torsades de Pointes Tachycardia
Torsades de pointes tachycardia is a serious arrhythmia that necessitates immediate medical attention.
Measures for Toxicity
If any symptoms of orphenadrine toxicity arise, it is crucial to seek medical help immediately.
Comparison Between Studies
Commonalities in Studies
Numerous studies have highlighted the anticholinergic nature of orphenadrine, which can lead to side effects like dry mouth, constipation, blurred vision, dizziness, and drowsiness.
Differences in Studies
Studies have shown variations in the severity and frequency of orphenadrine's side effects. Results on interactions between orphenadrine and other drugs also differ across studies. 22 indicates that orphenadrine effectively reduces extrapyramidal symptoms caused by haloperidol, 3 shows similar results for fluphenazine decanoate, and 25 highlights orphenadrine's effectiveness in reducing both extrapyramidal symptoms and depressive symptoms associated with fluphenazine decanoate. These studies collectively suggest that orphenadrine might be beneficial in managing extrapyramidal symptoms, but its efficacy may vary based on drug combinations and dosages.
Points to Note for Real-Life Applications
Orphenadrine is a medication with a range of potential side effects. Therefore, it's essential to adhere to your doctor's instructions and prescribed dosage when taking this medication. Promptly consult your doctor if any side effects emerge.
Limitations of Current Research
Research on the pharmacokinetics of orphenadrine is limited, especially concerning its pharmacokinetics in elderly patients and individuals with impaired renal or hepatic function. Furthermore, research on the long-term effects of orphenadrine is insufficient. 28 emphasizes the need for more pharmacokinetic data, particularly in the elderly, to ensure safe and effective use of orphenadrine.
Future Research Directions
Continued research on the pharmacokinetics of orphenadrine is crucial, with a particular focus on the elderly and patients with impaired renal or hepatic function. Additionally, research on the long-term effects of orphenadrine is necessary. Furthermore, elucidating the mechanisms underlying orphenadrine's side effects and developing novel medications to mitigate these side effects are essential research areas.
Conclusion
Orphenadrine, an anticholinergic medication, carries the potential for various side effects. Adhering to your doctor's instructions and prescribed dosage is crucial when taking orphenadrine. Consult your doctor immediately if any side effects develop. Further research on the safety of orphenadrine is essential to ensure its safe and effective use.
Benefit Keywords
Risk Keywords
Article Type
Author: LankampD J, WillemseJ, PikaarS A, van HeystA N
Language : English
Author: GjerdenPål, SlørdalLars, BramnessJørgen G
Language : English
Author: WistedtB
Language : English
Author: KnittelJessica L, VorceShawn P, LevineBarry, HughesRhome L, BosyThomas Z
Language : English
Author: SoaresK V, McGrathJ J
Language : English
An experimental evaluation of the euphoric properties of antiparkinson drugs on psychotic patients.
Author: VågenR, GötestamK G
Language : English
Language : English
Author: MaliziaE, SarcinelliL, PascarellaM, AmbrosiniM, SmeriglioM, RussoA
Language : English
Author: RichardsBethan L, WhittleSamuel L, BuchbinderRachelle
Language : English
Author: GukalovA A, KlypaT V, Mandel'I A, MinetsA I
Language : Russian
Author: GombotzHans, LochnerRegina, SiglRudolf, BlaslJohann, HerzerGünther, TrimmelHelmut
Language : English
Author: NicholsonKatherine L, BalsterRobert L
Language : English
Author: FuJonathan L, PerloffMichael D
Language : English
Author: BergmanHanna, Soares-WeiserKarla
Language : English
[Pilot study on the effects of an antiparkinson anticholinergic agent during depressive conditions].
Author: GisselmannA, MarinA, SimonP
Language : French
Author: ScholzEberhard P, KonradFranziska M, WeissDaniel L, ZitronEdgar, KieseckerClaudia, BloehsRamona, KulzerMartin, ThomasDierk, KathöferSven, BauerAlexander, MaurerMartin H, SeemannGunnar, KatusHugo A, KarleChristoph A
Language : English
Author: BorsodiMarianna, NagyEdina, DarvasKatalin
Language : Hungarian
Author: HoffmanB F
Language : English
Author: UitzE, AglasF, WurmA, RainerF
Language : German
Pilot study of orphenadrine as a novel treatment for muscle cramps in patients with liver cirrhosis.
Author: Abd-ElsalamSherief, El-KallaFerial, AliLobna A, MosaadSamah, AlkhalawanyWalaa, ElemaryBerihan, BadawiRehab, ElzeftawyAsmaa, HanafyAmr, ElfertAsem
Language : English
Author: SørensenH C, Munk-JørgensenP
Language : English
Author: AltamuraA C, BuccioM, ColomboG, TerziA, CazzulloC L
Language : English
Author: GjerdenP, SlørdalL
Language : Norwegian
Author: AltamuraA C, MauriM C, De NovellisF, PercudaniM, VampiniV
Language : English
Author: CapstickN, PudneyH
Language : English
Author: HarrisonL I, KeheC R, GoldlustM B, KvamD C, BianchineJ R
Language : English
Traditional pharmacological treatments for spasticity. Part II: General and regional treatments.
Author: GraciesJ M, NanceP, ElovicE, McGuireJ, SimpsonD M
Language : English
Author: BrocksD R
Language : English
Author: MálekJ, NedĕlováI, LopourováM, StefanM, KostálR
Language : Czech
Author: Abd-ElsalamSherief, EbrahimShaimaa, SolimanShaimaa, AlkhalawanyWalaa, ElfertAsem, HawashNehad, ElkadeemMahmoud, BadawiRehab
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.